id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-2011-P-0482-0004,FDA,FDA-2011-P-0482,"Determination That VAGIFEM (Estradiol) Vaginal Tablets, 25
Micrograms, Was Not Withdrawn From Sale for Reasons of Safety or
Effectiveness",Notice,Determinations,2015-05-22T04:00:00Z,2015,5,2015-05-22T04:00:00Z,,2015-05-22T14:53:04Z,2015-12396,0,0,0900006481af155a
FDA-2011-P-0482-0005,FDA,FDA-2011-P-0482,FDA CDER to Novo Nordisk Inc.  Citizen Petition Partial Approval and Partial Denial,Other,Partial Petition Approval and Denial,2015-05-22T04:00:00Z,2015,5,2015-05-22T04:00:00Z,,2015-05-22T18:10:45Z,,0,0,0900006481af2474
FDA-2011-P-0482-0003,FDA,FDA-2011-P-0482,"FDA/CDER Interim Response to Novo Nordisk, Inc. - Letter",Other,Letter(s),2011-12-16T05:00:00Z,2011,12,2011-12-16T05:00:00Z,,2011-12-17T00:49:35Z,,0,0,0900006480f844a9
FDA-2011-P-0482-0002,FDA,FDA-2011-P-0482,"Acknowledgement Letter to Novo Nordisk, Inc.",Other,Petition(s),2011-07-08T04:00:00Z,2011,7,2011-07-08T04:00:00Z,,2011-07-08T16:41:32Z,,0,0,0900006480e69adb
FDA-2011-P-0482-0001,FDA,FDA-2011-P-0482,"Novo Nordisk, Inc. - Citizen Petition",Other,Petition(s),2011-07-08T04:00:00Z,2011,7,2011-07-08T04:00:00Z,,2019-07-08T15:16:43Z,,0,0,0900006480e69aa7